
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis
Weinan Guo, Zhenjie Wu, Jianru Chen, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 6, pp. e004381-e004381
Open Access | Times Cited: 80
Weinan Guo, Zhenjie Wu, Jianru Chen, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 6, pp. e004381-e004381
Open Access | Times Cited: 80
Showing 1-25 of 80 citing articles:
Advancements in nanoparticle-based treatment approaches for skin cancer therapy
Leli Zeng, B.H. Jaswanth Gowda, Mohammed Gulzar Ahmed, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 193
Leli Zeng, B.H. Jaswanth Gowda, Mohammed Gulzar Ahmed, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 193
From Molecular Mechanisms to Therapeutics: Understanding MicroRNA-21 in Cancer
Jiho Rhim, Woosun Baek, Yoona Seo, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2791-2791
Open Access | Times Cited: 83
Jiho Rhim, Woosun Baek, Yoona Seo, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2791-2791
Open Access | Times Cited: 83
Ferroptosis in sepsis: The mechanism, the role and the therapeutic potential
Lei XL, Zhao GY, Rongxian Guo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 72
Lei XL, Zhao GY, Rongxian Guo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 72
Non-coding RNA-mediated modulation of ferroptosis in cardiovascular diseases
Ying Liu, Wei Ding, Jianxun Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114993-114993
Open Access | Times Cited: 50
Ying Liu, Wei Ding, Jianxun Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114993-114993
Open Access | Times Cited: 50
Mechanisms and applications of radiation-induced oxidative stress in regulating cancer immunotherapy
Zhuangzhuang Zheng, Jing Su, Xueying Bao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 44
Zhuangzhuang Zheng, Jing Su, Xueying Bao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 44
MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways
Arefeh Zabeti Touchaei, Sogand Vahidi
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 32
Arefeh Zabeti Touchaei, Sogand Vahidi
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 32
The crosstalk of CD8+ T cells and ferroptosis in cancer
Zhengjun Lin, Songzhu Zou, Kunming Wen
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 23
Zhengjun Lin, Songzhu Zou, Kunming Wen
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 23
Mechanisms, combination therapy, and biomarkers in cancer immunotherapy resistance
Manshi Yang, Mengying Cui, Yang Sun, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 17
Manshi Yang, Mengying Cui, Yang Sun, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 17
HMGA1 drives chemoresistance in esophageal squamous cell carcinoma by suppressing ferroptosis
Jingyu Yang, Xin‐Yuan Lei, Kai-Yue He, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 15
Jingyu Yang, Xin‐Yuan Lei, Kai-Yue He, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 15
Quercetin alleviates lipopolysaccharide‑induced acute lung injury by inhibiting ferroptosis via the Sirt1/Nrf2/Gpx4 pathway
Shihua Deng, Jin Li, Li Li, et al.
International Journal of Molecular Medicine (2023) Vol. 52, Iss. 6
Open Access | Times Cited: 34
Shihua Deng, Jin Li, Li Li, et al.
International Journal of Molecular Medicine (2023) Vol. 52, Iss. 6
Open Access | Times Cited: 34
Prospects for Anti-Tumor Mechanism and Potential Clinical Application Based on Glutathione Peroxidase 4 Mediated Ferroptosis
Mingliang Chen, Zhi‐Hao Shi, Yuqiu Sun, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1607-1607
Open Access | Times Cited: 30
Mingliang Chen, Zhi‐Hao Shi, Yuqiu Sun, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1607-1607
Open Access | Times Cited: 30
Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy
Yuting Wu, Xi Pu, Xu Wang, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Yuting Wu, Xi Pu, Xu Wang, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Regulated cell death‐amplified sonodynamic anti‐tumor immune nanotherapeutics
Liqiang Zhou, Yangmengfan Chen, Dong Xie, et al.
BMEMat (2024)
Open Access | Times Cited: 14
Liqiang Zhou, Yangmengfan Chen, Dong Xie, et al.
BMEMat (2024)
Open Access | Times Cited: 14
Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance
Hongquan Wang, Joshua S. Fleishman, Sihang Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Hongquan Wang, Joshua S. Fleishman, Sihang Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Melanoma biology and treatment: a review of novel regulated cell death-based approaches
Ming-yun Hsieh, Sheng‐Kai Hsu, Tzu‐Yu Liu, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 11
Ming-yun Hsieh, Sheng‐Kai Hsu, Tzu‐Yu Liu, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 11
Ferroptosis of T cell in inflammation and tumour immunity
Xueli Xia, Haisheng Wu, Yuxuan Chen, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 3
Open Access | Times Cited: 1
Xueli Xia, Haisheng Wu, Yuxuan Chen, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 3
Open Access | Times Cited: 1
Relationship between miRNA and ferroptosis in tumors
Shang‐Ming Dai, Feng‐Jiao Li, Hui‐Zhi Long, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 32
Shang‐Ming Dai, Feng‐Jiao Li, Hui‐Zhi Long, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 32
Targeting Wnt/β-Catenin Signaling Exacerbates Ferroptosis and Increases the Efficacy of Melanoma Immunotherapy via the Regulation of MITF
Hao Wang, Hengxiang Zhang, Yuhan Chen, et al.
Cells (2022) Vol. 11, Iss. 22, pp. 3580-3580
Open Access | Times Cited: 30
Hao Wang, Hengxiang Zhang, Yuhan Chen, et al.
Cells (2022) Vol. 11, Iss. 22, pp. 3580-3580
Open Access | Times Cited: 30
Ferroptosis in tumors and its relationship to other programmed cell death: role of non-coding RNAs
Qi Zhang, Xinfeng Fan, Xinyu Zhang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Qi Zhang, Xinfeng Fan, Xinyu Zhang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Ferroptosis as a promising therapeutic strategy for melanoma
Na Ta, Xiaodong Jiang, Yongchun Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 18
Na Ta, Xiaodong Jiang, Yongchun Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 18
Role of LncRNA H19 in tumor progression and treatment
Linjing Li, Yuting Gao, Boyi Yu, et al.
Molecular and Cellular Probes (2024) Vol. 75, pp. 101961-101961
Open Access | Times Cited: 7
Linjing Li, Yuting Gao, Boyi Yu, et al.
Molecular and Cellular Probes (2024) Vol. 75, pp. 101961-101961
Open Access | Times Cited: 7
Ferroptosis crosstalk in anti-tumor immunotherapy: molecular mechanisms, tumor microenvironment, application prospects
Y. F. Lu, Xiao‐Ting Xie, Lianxiang Luo
APOPTOSIS (2024) Vol. 29, Iss. 11-12, pp. 1914-1943
Closed Access | Times Cited: 7
Y. F. Lu, Xiao‐Ting Xie, Lianxiang Luo
APOPTOSIS (2024) Vol. 29, Iss. 11-12, pp. 1914-1943
Closed Access | Times Cited: 7
Advances in Melanoma: From Genetic Insights to Therapeutic Innovations
Fernando Valdez-Salazar, Luis Alberto Jiménez-Del Río, Jorge Ramón Padilla‐Gutiérrez, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1851-1851
Open Access | Times Cited: 6
Fernando Valdez-Salazar, Luis Alberto Jiménez-Del Río, Jorge Ramón Padilla‐Gutiérrez, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1851-1851
Open Access | Times Cited: 6
Identification and validation of ferroptosis-related gene signature in intervertebral disc degeneration
Qian Xiang, Yongzhao Zhao, Weishi Li
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 15
Qian Xiang, Yongzhao Zhao, Weishi Li
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 15
The Regulation of Ferroptosis by Noncoding RNAs
Xiangnan Zheng, Cen Zhang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13336-13336
Open Access | Times Cited: 14
Xiangnan Zheng, Cen Zhang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13336-13336
Open Access | Times Cited: 14